Lihat Juga

Paul Bijl: "Diskursus Kartini: Di Belanda Menjadi Paradoks, di Indonesia memiliki banyak wajah, di UNESCO merupakan figur kemanusiaan"

Andi Misbahul Pratiwi

Jakarta : Yayasan Jurnal Perempuan, 2015

Indeks Artikel Jurnal-Majalah

Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Foundations of cost-effectiveness analysis for health and medical practices, Milton C. Weinsrein; StasonWilliam B.; 2. Cost-effectiveness analysis: an introductory guide for clinicians, Marcones, George A; 3. Developmentof WHO guidelines on generalized cost-effectiveness analysis, Murray, Christopher J.L; (et al); 4. Cost analysis in primary health care: a training manual for programme managers, Andrew Creese; 5. Public hospitals in developing countries: resource use, cost, financing, Howard Barnum; 6. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 7. National price levels and the prices of tradables and nontradables, Irving B. Kravis; 8. For here or to go ? Purchasing power parity and the big mac, Michael R. Pakko; 9. Cost-analysis: issues and methodologies, Anandarup Ray; 10. THe Penn World Table (PWT) estimates of purchasing power parities and consumption, invesment, and governt price parities for non-benchmark countries (with special reference to PWT 5.6), Alan Heston; 11. The real and nominal? making inflationary adjusments to cost and other economic data, Lilani Kumaranayake; 12. Discounting human lives, Maureen L Cropper; 13. Methods for the economic evaluation of health care programmes, Michael F. Drummond; 14. Time preference, J. Lipscomp; 15. Time preference in medical making and cost-effectiveness analysis , Donald A Redelmier; 15. Discounting costs and effects: a reconsideration, Ben A. Van Hout; 16. Valuing health care: costs, benefits, and effectiveness of pharmaceuticals and other medical technologies, FRank A. Sloan; 17. Standardizing methodologies for economic evaluation in health care: practice, problems, and potential, Michael Drummond; 18. How much does excess inpatient capacity really cost ?, Parves R. Sopariwala; 19. Applying ABC to healthcare: as rising costs impact managed care, a successful manufacturing costing method is being applied to help managers make decisions on capitation contract bidding, cost containment, and organizational structure, Twothy D. West; 20.. IMCI multi-country evaluation form 5 A: health facility costs questionnaire; 21. The usefulness of rations for allocation decisions: the case of stroke, A. Ament; 22. A review of the use of health status measures in economic evaluation, J Brazier; 23. Preference-based measures in economic evaluation in health care, Peter J. Neumann; 24. Multi-aatribute preference functions: health utilities index, George W. Torrance; 25. Utilities and quality-adjusted life years, George W. Torrance; 26. Disability-adjusted life years: a critical review, Sudhir anand; 27. Understanding DALYs, Christopher J.L. Murray; 28. QALYs, HYEs and individualpreferences - a graphical illustration, Magnus Johannesson; 29. What randomized trials and systematic reviews can offer decision makers, Douglas G. Altman; 30. Evaluation of health interventions at area and organisation level, Obioha C Ukoumunne; 31. Interpreting the evidence: choosing between randomised and non-randomised studis, Martin McKee; 32. An evidence based approach to individualising treatment, Paul P. Glasziou; 33. Efficacy and effectiveness issues in the NIDA cooperative agreement: interventions for out-of-teatment drug-users; 34. The practice of antenatal care: comparing four study sites in different parts of the world participating in the WHO antenatal care rondomized controlled trial, Gilda Piaggio; 35. Behavioral issues in the efficacy versus effectiveness of pharmacologic agents in the prevention of cardiovascular disease, Thommas A. Pearson)

[s.l.] : Geneva: WHO, 2000, s.a.]

Prosiding

Workshop on evidence for health policy: burden of disease, cost-effectiveness, and health systems. (Daftar isi: 1. Compositional models for mortality by age, sex and cause, Joshua A Salomon; 2. The epidemiological transitional: policy and planning implications for developing countries, James N. Gribble; 3. Methodology for measuring health-state preferences - 1: measurement strategies, Debra G. Froberg; 4. Methodology for measuring health-State preferences - II: scaling methods, Debra G. Froberg; 5. Methodology for measuring health-State preferences - III: population and context effects, Debra G. Froberg; 5. Measurement of health state utilities for economic appraisal : a review, George W. Torrance; 7. Methods for quality adjusment of life years, Erik Nord; 8. The person-trade-off approach to valuing health care programs, Erik Nord; 9. Cost utility analysis: what should be measured?, J. Richardson; 10. Health state valuations from the general public using the visual analogue scale, C Gudex; 11. Modeling valuations for EuroQol health states, Paul Dolan; 12. Deriving preference-based single index from the UK SF-36 health survey, John Brazier; 13. Measuring preferences for health states worse than death, Donald L. Patrick; 14. Multiattribute utility function for a comprehensive health status classification system health utilities index mark 2, George W. Torrance; 15. Evaluating healthy days of life gained from health projects, Howard Barnum; 16. The utility of health at different stages in life: a quantitative approach, Jan J. V.B; 17. The economic cost of illness revisited, Barbara S. Cooper; 18. Is the valuation of a qaly gained independent of age? some empirical evidence, Magnus J; 19. Discounting in the economic evaluation of health care interventions, Murray K; 20. Maximizing health benefits vs egalitarianism: an Australian survey of health issues, Erik N; 21. Estimating the cost of illness, Dorothy P.R.; 22. Discounting in health care decision-making: time for a change ?, Trevor A. Sheldon; 23. Discounting the future: influence of the economic model, Robert R. West; 24. Penn world tables 5.6, Alan H; 25. On the comparable quantification of health risks: lessons from the global burden of disease study, Christophr J.L.M; 26. Conceptual problems in the definition and interprtation of attributable fractions, Sander G; 27. Estimability and estimation of excess and etiologic fractions, James M. Robin; 28. Reducing the global burden of blood pressure-related cardiovascular disease, Anthony R; 29. The Australian burden of disease study: measuring the loss of health from diseses, injuries and risk factors, Colin DM; 30. Mortality in relation to smoking: 40 years' observations on male British doctors, Richard D; 31. Estimated numbers of deaths from coronary heart disease "Caused" and "prevented" by alcohol: an example from Finland, Pia M; 32. Mortality from tobacco in developed countries: indirect estimation from national vital statistics, Richard P.A; 33. Intake of fatty acids and risk of coronary heart disease in a cohort of finnish men, Pirjo Pietinen; 34. Alcohol consumption and mortality among middle-aged and elderly U.S. adults, Michael J. Thun; 35. An improved aetiologic fraction of alcohol caused morbidity and mortality; 36. Dietary fat intake and the risk of coronary heart disease in women, Frank B. Hu; 37. Obesity, mortality and cardiovascular disease in the munster heart study (PROCAM), Helmut S; 38. The burden of dsease in Mexico in 1994: advances and challenges, Rafael Lozano; 39. The burden of disease and injury in Australia, Colin Mathers)

[s.l.] : Geneva: WHO, 2000, s.a.]

Prosiding